RecruitingNot ApplicableNCT05384561

Olfactory Training As a Treatment for Olfactory Dysfunction Post COVID-19

L'entraînement Olfactif Comme Traitement De La Dysfonction Olfactive Post COVID-19


Sponsor

Université du Québec à Trois-Rivières

Enrollment

70 participants

Start Date

May 31, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

Olfactory dysfunction is a defining symptom of COVID-19 infection. Studies have demonstrated improved olfaction in patients with post infectious olfactory dysfunction after an olfactory training (OT). The aim of this study is to assess the clinical outcomes of olfactory training (12 weeks) therapy in the treatment of persistent olfactory dysfunctions after COVID-19. Specially, we aim to compare the effectiveness of two different olfactory training (different odors). A group will train themselves with 4 scents (rose, orange, clove and eucalyptus) and another group with 4 different scents (cheese, coffee, strawberries and lemon). Olfaction sensory evaluation will be performed by using different olfaction tests (Sniffin' Sticks and UPSIT) and complete questionnaires to assess olfactory perception and particularly parosmia and phantosmia.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Smell training for people with anosmia, covid-19, and other related conditions. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERSmell training

For 12 weeks, morning and evening, smell four different odors or four odorless substances for a total of five minutes per session.


Locations(1)

Université du Québec à Trois-Rivières

Trois-Rivières, Quebec, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05384561


Related Trials